Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 9
Submit an article Journal homepage
713
Views
31
CrossRef citations to date
0
Altmetric
Author's View

Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells

Matilde Todaro Biomedical Research Centre; University of Palermo; Palermo, Italy; Department of Surgical and Anatomical Disciplines; University of Palermo; Palermo, Italy
,
Serena Meraviglia Department of Biopathology and Biotechnology; University of Palermo; Palermo, Italy
,
Nadia Caccamo Biomedical Research Centre; University of Palermo; Palermo, Italy; Department of Biopathology and Biotechnology; University of Palermo; Palermo, Italy
,
Giorgio Stassi Department of Surgical and Anatomical Disciplines; University of Palermo; Palermo, Italy
&
Francesco Dieli Biomedical Research Centre; University of Palermo; Palermo, Italy; Department of Biopathology and Biotechnology; University of Palermo; Palermo, ItalyCorrespondence[email protected]
Article: e25821 | Received 19 Jul 2013, Accepted 20 Jul 2013, Published online: 29 Jul 2013

References

  • Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Cancer stem cells--old concepts, new insights. Cell Death Differ 2008; 15:947 - 58; http://dx.doi.org/10.1038/cdd.2008.20; PMID: 18259194
  • Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5:275 - 84; http://dx.doi.org/10.1038/nrc1590; PMID: 15803154
  • Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J Clin 2012; 62:309 - 35; http://dx.doi.org/10.3322/caac.20132; PMID: 22576456
  • Vantourout P, Hayday A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol 2013; 13:88 - 100; http://dx.doi.org/10.1038/nri3384; PMID: 23348415
  • Mattarollo SR, Kenna T, Nieda M, Nicol AJ. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer Immunol Immunother 2007; 56:1285 - 97; http://dx.doi.org/10.1007/s00262-007-0279-2; PMID: 17265022
  • Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, et al. Contribution of IL-17-producing γ δ T cells to the efficacy of anticancer chemotherapy. J Exp Med 2011; 208:491 - 503; http://dx.doi.org/10.1084/jem.20100269; PMID: 21383056
  • Todaro M, D’Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, et al. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 2009; 182:7287 - 96; http://dx.doi.org/10.4049/jimmunol.0804288; PMID: 19454726
  • Todaro M, Orlando V, Cicero G, Caccamo N, Meraviglia S, Stassi G, et al. Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity. PLoS One 2013; 8:e65145; http://dx.doi.org/10.1371/journal.pone.0065145; PMID: 23762301
  • Wang S. TRAIL: a sword for killing tumors. Curr Med Chem 2010; 17:3309 - 17; http://dx.doi.org/10.2174/092986710793176285; PMID: 20712573

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.